Vaccination News Home Page

http://www.portal.telegraph.co.uk/news/main.jhtml?xml=/news/2002/08/09/nmmr09.xml&sSheet=/news/2002/08/09/ixhome.html

| | | | | |
news.telegraph.co.uk
Save this page to your clipboard Email this page to a friend Print this page as text only
telegraph.co.uk
News home
Business news
Crossword Society
Feedback
Golden Jubilee
Law reports
Matt cartoon
Obituaries
Opinion
Weather
War on terrorism
About us
Contact us

 
 


 

Study linking autism to MMR is published
By David Derbyshire, Science Correspondent
(Filed: 09/08/2002)
 

One of the scientists who believes that there may be a connection between autism and the measles, mumps and rubella vaccine has published new research suggesting a link.

Dr Vijendra Singh, of Utah State University, found that many children with the developmental disorder had an "inappropriate immune response" to the measles component of the vaccine.

Although Dr Singh has presented similar studies before, the new research on 125 autistic children and 92 children without autism appears in a peer-reviewed scientific journal.

The researchers found a "significant increase" in MMR antibodies in the blood of autistic children. The measles component caused an unusual antibody response in 60 per cent of the children with autism, compared with none of the 92 children without the condition.

Dr Singh has argued that autism may be caused by an autoimmune response in which antibodies target the basic building blocks of myelin, the insulating sheath that covers nerve fibres. His latest paper, in the Journal of Biomedical Science, does not prove that MMR causes autism; autism may be responsible for the unusual response to the MMR antibodies.

However, in the journal, Dr Singh and colleagues report: "Stemming from this evidence, we suggest that an inappropriate antibody response to MMR, specifically the measles component thereof, might be related to pathogenesis of autism."

MMR vaccine uptake for 16-month-old children fell from 76.2 to 70.1 per cent between December and March, but rose to 72 per cent in April. Uptake for 24-month-old children fell from 85.8 per cent to 84.4 per cent over the same winter period, then rose to 85.9 per cent.

The Public Health Laboratory Service, Department of Health and British Medical Association have all consistently said the vaccine is safe.

But the pressure group Jabs (Justice, Awareness and Basic Support), said the new research strengthened its case for the suspension of MMR use.

Jonathan Harris, a spokesman, said: "We have said all along that it affects only a certain subset of children, causing a new type of autism in children whose immune systems have not really been tested fully."

 

9 July 2002: Fathers contest mothers' MMR ban in court
7 July 2002: Alternative rubella jab to MMR is discontinued
4 July 2002: Doctors attack Livingstone comments on MMR vaccine
3 July 2002: Doctors abandon bonus scheme for MMR jabs
28 June 2002: MMR 'may be linked to certain type of autism'
23 June 2002: US experts back MMR doctor's findings
17 May 2002: MMR jabs increase as debate cools off

 

Previous story: Children hit by swimming pool parasite
Next story: NHS trust 'knew gynaecologist was struck off'
 

 
External links  
 
Biotech centre - Utah State University
 
Abnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism [26 Jul '02] - Journal of Biomedical Science
 
Why is MMR vaccine preferable to single vaccines? [Jul '02] - Public Health Laboratory Service
 
Measles Mumps and Rubella vaccine - Chief Medical Officer
 
MMR immunisation [8 Feb '02] - British Medical Association
 

 

 

 

 

Telegraph Fantasy Football Online

 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.